Bioxytran, Inc. (OTCMKTS:BIXT) Sees Significant Drop in Short Interest

Bioxytran, Inc. (OTCMKTS:BIXT) was the target of a large drop in short interest in the month of January. As of January 15th, there was short interest totalling 10,300 shares, a drop of 86.7% from the December 31st total of 77,600 shares. Based on an average daily trading volume, of 153,100 shares, the days-to-cover ratio is presently 0.1 days.

Bioxytran Stock Up 0.5 %

Bioxytran stock traded up $0.00 during mid-day trading on Tuesday, hitting $0.09. 57,813 shares of the company’s stock were exchanged, compared to its average volume of 244,877. The firm has a market capitalization of $8.19 million, a P/E ratio of -9.44 and a beta of -0.55. Bioxytran has a fifty-two week low of $0.06 and a fifty-two week high of $0.15. The company’s 50 day simple moving average is $0.09 and its 200-day simple moving average is $0.10.

About Bioxytran

Bioxytran, Inc, a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company’s lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke, and hypoxic conditions in wounds to prevent necrosis and to promote healing.